Geron Corporation (GERN)

4.4100 +0.1600 (+3.76%) At close: 04:00PM EDT

Geron Corporation

919 East Hillsdale Boulevard
Suite 250
Foster City, CA 94404
United States
650 473 7700
https://www.geron.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 141

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. John A. Scarlett M.D.	Chairman of the Board, President & CEO	1.36M	N/A	1951
Ms. Michelle J. Robertson	Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer	340.98k	N/A	1967
Dr. Andrew J. Grethlein Ph.D.	Executive VP & COO	827.01k	N/A	1964
Mr. Scott Samuels	Executive VP, Chief Legal Officer & Corporate Secretary	485.32k	N/A	N/A
Ms. Aron Feingold	Vice President of Investor Relations & Corporate Communications	N/A	N/A	N/A
Ms. Shannon Odam	Senior VP & Chief People Officer	N/A	N/A	1975
Ms. Melissa A. Kelly Behrs	Executive VP of Business Operations & Chief Alliance Officer	753.22k	N/A	1964
Mr. Edward E. Koval	Executive VP & Chief Business Officer	N/A	N/A	1962
Dr. Faye Feller M.D.	Executive VP & Chief Medical Officer	N/A	N/A	1983

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Corporate Governance

Geron Corporation’s ISS Governance QualityScore as of September 1, 2024 is 7. The pillar scores are Audit: 7; Board: 6; Shareholder Rights: 9; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.